:
The novel coronavirus infection (COVID‐19) is a global public health emergency.Since its outbreak in Wuhan,
China in December 2019, the infection has spread at an alarming rate across the globe and humans have been locked down
to their countries, cities and homes. As of now, the virus has affected over 20million people globally and has inflicted over 7
lac deaths. Nevertheless, the recovery rate is improving with each passing day and over 14 million people have recuperated
so far. The statistics indicate that nobody is immune to the disease as the virus continues to spread among all age groups;
newborns to the elders, and all compartmentsincluding pregnant women. However, pregnant women may be more susceptible to this infection as they are, in general, highly vulnerable to respiratory infections. There is no evidence for vertical
transmission of the COVID-19 virus among pregnant women, but an increased prevalence of preterm deliveries. Besides
this, the COVID-19 may alter immune response at the maternal-fetal interface and affect the well-being of mothers as well
as infants. Unfortunately, there is limited evidence available in the open literature regarding coronavirus infection during
pregnancy and it now appears that certain pregnant women have infected during the present 2019-nCoV pandemic. In this
short communication, we study the impact of the COVID-19 infection on vertical transmission and fetal outcome among
pregnant women.
CORONAVIRUS INFECTION (SARS-CoV-2) IN PREGNANT WOMEN: SYSTEMATIC REVIEW
